Researchers at the University of Pittsburgh say a new minimally invasive intervention can target the root cause of neural function loss.

Cold weather doesn’t just bring discomfort; it wages war on my nervous system. As the temperature drops, function fades, and pain rises. Some days, I wake up feeling as if my body has been frozen in ...

The TSXV serves as a vital platform for early-stage, high-growth companies, providing access to capital and a strong investor network. In 2024, 80% of the TSXV Venture 50™ companies operated ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid ...

A woman developed an array of symptoms shortly after returning from a vacation, and parasites turned out to be the culprit.

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...

Multiple sclerosis home adaptations that include adaptive equipment and technology can help prevent falls for people living ...

Transformational' research aims to create prosthetic hands that not only look natural but also feel intuitive to use ...